In tackling cardiovascular diseases, India should come in forefront with greater strategies. Cardiovascular diseases are alarmingly on high rise among youths also. Being developing country India must learn from US and adopt strategies which can have a potential explanation from differences . Learn strategies for improving Indian cardiovascular health behaviors, systems, and policies. India’s CVD prevalence has increased over the last two decades due to population growth, aging and reliable age-adjusted CVD mortality.

During the same period, in the United States, age-adjusted CVD mortality rates declined overall, but trends began to stagnate. These improvements in CVD mortality in the United States also contributed to improved secondary prevention and acute care, but primarily due to the trend of favorable population-level risk factors related to smoking, cholesterol and blood pressure. To reduce premature mortality and disability from CVD and to achieve similar benefits, India needs to strengthen and integrate regional, regional and national health systems while enforcing population-level policies. Achieving national all-insurance, including economic risk protection, continues to be a goal to help all Indians realize their right to health and tackling cardiovascular diseases.

 Prediction of machine learning in cardiovascular disease: A meta-analysis to our knowledge, this is the first and largest new meta-analysis method so far in ML research, derived from a huge number of studies involving over 1 million participants, ML reports cardiovascular Algorithmic prediction of disease. In the context, the Hulamin Gum score overestimates CVD risk and may lead to overtreatment. Interestingly, HF results are inconclusive. Tackling cardiovascular disease has been a grave concern nowadays.

 If these studies are showing predictive benefits based on ML, an optimal algorithm can be implemented through electronic health records (EHR) and facilitate application in clinical practice. The EHR implementation is well-suited for ML-based predictions to reduce reliance on various variables, such as discrete checkpoints with easy access to data. 

Tackling Cardiovascular Disease: What India Can Learn from America India reports 63% of all deaths from non-communicable diseases, of which 27% were attributable to cardiovascular disease (CVD). This improvement in CVD mortality in the United States is largely due to improved acute treatment and management of risk factors for heart disease such as tobacco use, cholesterol and blood pressure. For example, imagine a farmer who visits a PHC near his town once every two months. They don’t always carry files or subsequent documents with each visit. India Focus should be placed on controlling risk as LMIC develops into developed countries and preventing the transition to complete heart disease. 

 India’s policy level to achieve a clear success rate in the United States. The focus is on preventable mortality, says Chandrakant Lahariya, a public health policy expert who worked at the World Health Organization (WHO) until recently. The century has changed and cardiovascular disease (CVD) is the main cause. India mortality. On December 11, 2018, India took a very important step for official recruitment and implementation.

Currently, the tests proposed by the WHO EDL are limited to in vitro diagnosis and do not include other modalities such as coronary angiography and non-invasive imaging. Therefore, the Indian NLED must distinguish the examinations at the various layers of the Indian public health system. The four tiers of the Indian public health system include sub-health centers, primary health centers, community health centers and community hospitals.

Given its prevalence, we believe it is important to provide a diagnosis of these conditions at the primary health center level, including a lipid panel creatinine and electrolytes and liver function tests. However, in many cases, robust sample delivery systems do not exist in low- and middle-income countries, and it is expected that patients will either move to the upper classes on their own or require testing in the private sector. Thus can help in tackling cardiovascular diseases.